JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$761M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$735M |
| 3 |
Zimmer Biomet
ZBH
|
+$542M |
| 4 |
Amazon
AMZN
|
+$439M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$438M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.01B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$1.11B |
| 3 |
AABA
Altaba Inc
AABA
|
+$699M |
| 4 |
TJX Companies
TJX
|
+$682M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.01% |
| 2 | Financials | 14.82% |
| 3 | Technology | 12.49% |
| 4 | Healthcare | 9.61% |
| 5 | Consumer Discretionary | 8.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SGY
3026
DELISTED
Stone Energy
SGY
| $2.56M | ﹤0.01% |
79,662
-235,338
| -75% | -$6.84M |
2017 Q1
3 quarters
|
|
3027
AMERISAFE
AMSF
$438M
| $2.56M | ﹤0.01% |
41,510
+21,316
| +106% | +$1.34M |
2013 Q2
18 quarters
|
|
3028
Alarm.com
ALRM
$2.7B
| $2.55M | ﹤0.01% |
67,604
-4,966
| -7% | -$214K |
2017 Q3
1 quarter
|
|
|
EVBG
3029
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.55M | ﹤0.01% |
85,760
+53,534
| +166% | +$1.46M |
2017 Q3
1 quarter
|
|
3030
Corvus Pharmaceuticals
CRVS
$921M
| $2.54M | ﹤0.01% |
245,461
-70,739
| -22% | -$906K |
2016 Q2
6 quarters
|
|
3031
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.28B
| $2.54M | ﹤0.01% |
+83,315
| New | +$2.54M |
2017 Q4
0 quarters
|
|
3032
Utah Medical Products
UTMD
$236M
| $2.54M | ﹤0.01% |
31,200
-3,318
| -10% | -$259K |
2015 Q3
9 quarters
|
|
|
DO
3033
DELISTED
Diamond Offshore Drilling
DO
| $2.53M | ﹤0.01% |
136,175
-985,863
| -88% | -$16M |
2013 Q2
18 quarters
|
|
3034
Viasat
VSAT
$10B
| $2.53M | ﹤0.01% |
33,793
+32,981
| +4,062% | +$2.28M |
2016 Q4
4 quarters
|
|
3035
CRISPR Therapeutics
CRSP
$5.29B
| $2.52M | ﹤0.01% |
107,444
+76,787
| +250% | +$1.46M |
2017 Q3
1 quarter
|
|
3036
PUT
Kroger
KR
$34.8B
| $2.52M | ﹤0.01% |
91,900
+32,700
| +55% | +$762K |
2017 Q3
1 quarter
|
|
|
TGI
3037
DELISTED
Triumph Group
TGI
| $2.52M | ﹤0.01% |
92,752
+58,443
| +170% | +$1.75M |
2013 Q2
18 quarters
|
|
|
AVP
3038
DELISTED
Avon Products, Inc.
AVP
| $2.51M | ﹤0.01% |
1,168,367
+625,602
| +115% | +$1.34M |
2013 Q2
18 quarters
|
|
|
LKFT
3039
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.91B
| $2.5M | ﹤0.01% |
26,718
-3,211
| -11% | -$304K |
2017 Q3
1 quarter
|
|
3040
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
$2.8B
| $2.5M | ﹤0.01% |
51,065
+36,865
| +260% | +$1.8M |
2013 Q2
18 quarters
|
|
3041
Sportsman's Warehouse
SPWH
$43.4M
| $2.5M | ﹤0.01% |
378,133
+245,371
| +185% | +$1.18M |
2017 Q3
1 quarter
|
|
3042
State Street Real Estate Select Sector SPDR ETF
XLRE
$7.54B
| $2.49M | ﹤0.01% |
75,582
-2,168
| -3% | -$71.5K |
2016 Q2
6 quarters
|
|
3043
NovaGold Resources
NG
$2.87B
| $2.48M | ﹤0.01% |
632,301
-478,518
| -43% | -$1.9M |
2016 Q3
5 quarters
|
|
3044
FS KKR Capital
FSK
$3.03B
| $2.48M | ﹤0.01% |
84,503
+81,469
| +2,685% | +$2.62M |
2017 Q1
3 quarters
|
|
|
ARR
3045
Armour Residential REIT
ARR
$1.93B
| $2.48M | ﹤0.01% |
19,292
-56,390
| -75% | -$7.26M |
2015 Q3
9 quarters
|
|
|
SEE
3046
CALL
DELISTED
Sealed Air
SEE
| $2.46M | ﹤0.01% |
50,000
| – | – |
2017 Q3
1 quarter
|
|
|
HTZ
3047
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $2.46M | ﹤0.01% |
128,348
-53,243
| -29% | -$1.03M |
2016 Q3
5 quarters
|
|
|
NPKI
3048
NPK International
NPKI
$1.01B
| $2.46M | ﹤0.01% |
286,536
+16,851
| +6% | +$153K |
2016 Q4
4 quarters
|
|
3049
CareTrust REIT
CTRE
$8.6B
| $2.46M | ﹤0.01% |
146,796
+145,390
| +10,341% | +$2.69M |
2016 Q1
7 quarters
|
|
3050
Super Micro Computer
SMCI
$28.4B
| $2.45M | ﹤0.01% |
1,169,100
-927,950
| -44% | -$1.99M |
2016 Q4
4 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2017 Portfolio in Review
As of Q4 2017, JP Morgan Chase held 5,783 positions worth $475B, up 4.7% from $453B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q4 2017 filing shows 812 new, 2,513 increased, 1,655 reduced and 342 closed positions. Its largest new stake was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.01B.
By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 2,961,446 shares worth $155M.
- JP Morgan Chase added most to Johnson & Johnson in Q4 2017, an estimated $761M increase.
- JP Morgan Chase's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.01B.
- JP Morgan Chase fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $275M.
- JP Morgan Chase's ten largest holdings make up 18% of its $475B portfolio in Q4 2017.
- JP Morgan Chase opened 812 new positions and closed 342 in Q4 2017.
- JP Morgan Chase's portfolio value rose 4.7% quarter-over-quarter to $475B.
Based on JP Morgan Chase's 13F filing for Q4 2017, filed 13 Feb 2018.